Thai Medical Device Export: Surgical Instruments, Syringes, Bandages, and the BOI Med-Tech Cluster
Thai medical-device export ~USD 2-3B annual segment combining syringes, bandages, surgical-instruments, diagnostic, electrocardiogram. Bionova (private; tier-1 Thai medical-device), Eppendorf Thailand, Becton Dickinson Thailand (BD US-affiliated), Greiner Bio-One Thailand. BOI med-tech promotion 2024-2027, EEC. Watchpoints: EU CSDDD, US 19% tariff, Halal medical-device export, AI-enabled medical-device.
Key takeaways
- 1
- 2
Bionova tier-1 Thai medical-device manufacturer.
- 3
Foreign-affiliated tier-1: BD, Greiner, Terumo, Cook, Bausch, Lomb, Smith, Nephew.
- 4
BOI med-tech promotion 2024-2027 framework, EEC medical-device industrial-cluster.
- 5
Major export: US ~, EU ~, Japan, Korea ~, ASEAN ~, GCC, Africa, LatAm ~.
- 6
Watchpoints: EU CSDDD, US tariff, Halal medical-device export, AI, digital-health integration.
Questions this report answers
How big is Thai medical-device export? Per Customs / DITP: Thai medical-device export industry runs ~ annual export FY2024 β combining syringes, bandages, surgical-instruments, diagnostic, electrocardiogram, dental, orthopaedic. Tier-1 Thai: Bionova; foreign-affiliated tier-1: BD (US), Greiner Bio-One (Austrian), Terumo (Japanese), Cook Medical (US), Bausch, Lomb (US), Smith, Nephew (UK).[, , ]
What's BOI promotion, cluster? Per BOI: BOI med-tech promotion 2024-2027 framework, EEC medical-device industrial-cluster. Halal medical-device export significant for ASEAN-Muslim, GCC.[]
What's market mix, watchpoints? Per Bangkok Post: Major export: US (~), EU (~), Japan, Korea (~), ASEAN (~), GCC, Africa, Latin America (~). Watchpoints: EU CSDDD compliance, US tariff impact, Halal medical-device export expansion, AI-enabled medical-device, digital-health integration, Thai-medical-tourism intersection.[]
Executive summary
Thai medical-device export ~ annual segment. Bionova, BD, Greiner, Terumo, Cook tier-1.[, , ]
BOI med-tech promotion 2024-2027 framework, EEC industrial-cluster. Halal medical-device export.[]
US ~, EU ~, Japan+Korea ~ markets. Watchpoints: EU CSDDD, US tariff, AI, digital-health integration.[]
Thai medical-device export structure
Annual export
Value
~USD 2-3B
Notes
FY2024.
Foreign-affiliated tier-1
Value
BD/Greiner/Terumo/Cook/B+L/S+N
Notes
US, Austrian, Japanese, UK.
Bionova
Value
Tier-1 private Thai
Notes
Domestic medical-device.
BOI med-tech promotion
Value
2024-2027 framework
Notes
EEC industrial-cluster.
US export share
Value
Notes
Tier-1 buyer market.
Halal medical-device
Value
ASEAN, GCC export
Notes
Niche segment.
| Metric | Value | Notes |
|---|---|---|
| Annual export | ~USD 2-3B | FY2024. |
| Foreign-affiliated tier-1 | BD/Greiner/Terumo/Cook/B+L/S+N | US, Austrian, Japanese, UK. |
| Bionova | Tier-1 private Thai | Domestic medical-device. |
| BOI med-tech promotion | 2024-2027 framework | EEC industrial-cluster. |
| US export share | ~25% | Tier-1 buyer market. |
| Halal medical-device | ASEAN, GCC export | Niche segment. |
Analyst framing
Why this report matters
Unlock the full report
Need more than the web report? Ask for a scoped export or source appendix.
Every report keeps visible citations and source metadata. Terms.
Related reports
Bangkok Medical Tourism: BDMS, Bumrungrad, and the USD 4-6B Private-Hospital Health-Travel Tier
Bangkok is one of the world's top-3 medical tourism destinations. ~USD 4-6B annual Thai medical tourism segment; ~3-4M international patients annually. Tier-1 private hospital groups: BDMS (Bangkok Dusit Medical Services SET-listed BDMS, world's #5 hospital group by market cap, ~50 hospitals; founded by Prasert Prasarttong-Osoth, Pongsak Viddayakorn 1972), Bumrungrad International (BH SET-listed, single-flagship Sukhumvit Soi 3, JCI-accredited 2002 first in Asia), Praram 9 Hospital, Vejthani Hospital. Patient mix: GCC ~25-30%, ASEAN ~25%, Western ~20%, Chinese ~10%, African ~5-10%, Indian ~5-10%. Specialty: cardiology, orthopaedics, fertility/IVF, cancer, plastic surgery, dental tourism, gender-affirmation surgery (Thailand global tier-1). Watchpoints: GCC, ASEAN, Indian patient flow, JCI accreditation cadence, US medical-tourism trajectory, LTR Wellness visa, BDMS BMI Healthcare UK acquisition pipeline.
Open report β
Thai Pharmaceutical: GPO State Pharma, Generic Production, and the Patent-Pool ARV Heritage
Thai pharmaceutical industry ~USD 5-7B annual market. Government Pharmaceutical Organization (GPO, est 1966) is structural state-owned-pharma anchor β tier-1 generic manufacturer, medical-cannabis programme, COVID-vaccine production, emergency-stockpile coordinator. Thailand's compulsory-license heritage: 2007 Pheu Thai-precursor government issued compulsory licenses for ARV (anti-retroviral HIV/AIDS drugs) under WTO TRIPS+ public-health flexibility β global precedent-setting. Tier-1 private domestic: Berli Jucker (BJC, TCC Group-affiliated, including Cerebos health-food, Big C-pharmacy distribution), Mega Lifesciences (MEGA SET-listed Indian-Thai-affiliated), Olic Thailand (Thai-listed), Pharmasant Laboratories. Tier-1 foreign-MNC distributors: GSK Thailand, Pfizer Thailand, Novartis Thailand, Roche Thailand, Sanofi Thailand. Siam Bioscience (TBA SET-listed, Crown Property Bureau-affiliated) is biotech tier β produced AstraZeneca COVID-vaccine 2021-2022 under tech-transfer. Distribution: Pharmasant, Berli Jucker, Zuellig Pharma. Watchpoints: WTO TRIPS+ pressure, EU CSDDD compliance, biosimilar entry (Pfizer Hospira, Sandoz), BOI medical-device promotion, AOT-Phuket-Bangkok medical-tourism integration with GPO supply.
Open report β